Advancements in bone marrow transplant (BMT) techniques are giving new hope to people with blood cancers. A bone marrow, or stem cell, transplant replaces diseased blood-forming cells with healthy ones, and for some leukemias, lymphomas and myelomas it offers the chance of long-term control or cure. This page explains how bone marrow transplant works, who may need it, the types of transplant, recent advances, the risks and recovery, what to do when a transplant is not possible, and how supportive care and Welling Homeopathy’s Immuno-Knife Cancer Therapy are offered alongside oncology treatment.
Looking for supportive care for blood cancer?
Share your diagnosis, reports and current treatment, and our specialists will plan supportive homeopathic care alongside your oncology treatment, in person at our Mumbai clinics or online from anywhere.
Call +91 8080 850 950 for a 1:1 personal consultation with our experts today.
Bone marrow transplant at a glance
- What it is: replacing diseased bone marrow with healthy blood-forming stem cells, from the patient (autologous) or a donor (allogeneic).
- Who may need it: selected people with leukemia, lymphoma, myeloma and other marrow disorders.
- Advances: haploidentical (half-matched) family donors, reduced-intensity conditioning, better infection and graft-versus-host disease control, and CAR-T cell therapy.
- Risks: infections, graft-versus-host disease, organ damage, relapse and a long recovery.
- When not possible: age, other illness, no suitable donor or disease status may make other treatments more suitable.
How a bone marrow transplant works
Chemotherapy, with or without radiation, is used to clear the diseased marrow and, in an allogeneic transplant, to make room for the donor cells. Healthy stem cells are then given through a drip, travel to the bone marrow, and begin to make new blood cells over the following weeks.
- Autologous transplant: your own stem cells are collected, stored and returned after high-dose chemotherapy; commonly used in myeloma and some lymphomas
- Allogeneic transplant: stem cells from a matched sibling, an unrelated donor, a cord blood unit or a half-matched (haploidentical) family member; used in many leukemias and other conditions, where the donor immune cells also help fight the disease
Who benefits from a transplant?
| Condition | Role of transplant |
|---|---|
| Acute leukemias | Allogeneic transplant is often considered in first or second remission for higher-risk disease |
| Chronic leukemias and myelodysplasia | Considered for selected patients with high-risk or advanced disease |
| Lymphoma | Autologous transplant for relapsed disease; allogeneic in selected cases |
| Multiple myeloma | Autologous transplant is a standard option for suitable patients |
| Non-cancer marrow disorders | Aplastic anaemia, thalassaemia and sickle cell disease |
Transplant has been recognised as a potentially curative therapy for patients with blood cancers such as leukemia, lymphoma and myeloma, but the decision is individual and depends on the disease, remission status, age and fitness.
Recent advances
- Haploidentical transplants, which make a transplant possible for patients who lack a fully matched donor, a major advance in countries like India
- Reduced-intensity conditioning, allowing older or less fit patients to be considered
- Post-transplant cyclophosphamide and other strategies that reduce graft-versus-host disease
- Better antiviral, antifungal and supportive care, and improved donor registries
- CAR-T cell therapy and other immunotherapies for relapsed blood cancers, including CAR-T therapy developed and approved in India
Risks and recovery
- Infections while the immune system recovers, which can take months
- Graft-versus-host disease (GVHD) in allogeneic transplants
- Organ side effects of conditioning treatment, mouth sores, nausea and fatigue
- Relapse of the underlying disease
- Long-term follow-up for infertility, bone health, second cancers and emotional wellbeing
Most patients stay in a transplant unit for several weeks, and recovery of energy and immunity takes months to a year.
When a transplant is not possible or not ideal
Even though transplant therapy has advanced, it may not always be the ideal or feasible treatment for certain blood cancer patients, for example because of age, other illness, disease status or lack of a suitable donor. In such situations other treatments such as chemotherapy, targeted therapy, immunotherapy or CAR-T may be used, with supportive care to make the journey smoother.
Supportive care and the Immuno-Knife Cancer Therapy
Welling Homeopathy offers supportive homeopathic care to people with blood cancers, before, during and after their treatment, and never instead of it.
Our clinical experience with blood cancers
The Role of Immuno-Knife Therapy: A Versatile Approach For Blood Cancers. Even though Bone Marrow Transplant (BMT) therapy has seen considerable advancements, it may not always be the ideal or feasible treatment for certain blood cancer patients.
At such times, an alternative treatment option emerges – our Homeopathic Immuno-Knife Cancer Therapy.
The Immuno-Knife Therapy is not simply a second choice; it is a versatile therapeutic approach, showing enormous promise in making the patient’s journey smoother throughout the course of the disease.
In scenarios where BMT seems challenging, our Immuno-Knife Cancer Therapy steps up, offering hope and healing to blood cancer patients.
Call +91 8080 850 950 to book a personal consultation to check if our Immuno-Knife Cancer Therapy can be suitable for you. See also blood cancer early symptoms and homeopathy specialist for cancer.
Frequently asked questions about bone marrow transplant
1. What is a bone marrow transplant?
A procedure that replaces diseased bone marrow with healthy blood-forming stem cells, either your own (autologous) or from a donor (allogeneic).
2. Can a bone marrow transplant cure blood cancer?
For some blood cancers it can provide long-term control or cure, depending on the disease, remission status and the patient’s fitness.
3. What is a haploidentical transplant?
A transplant from a half-matched family member, such as a parent, child or sibling, which allows more patients to find a donor.
4. What are the main risks of a bone marrow transplant?
Infections, graft-versus-host disease, organ damage, relapse and a long recovery period.
5. How long is recovery after a bone marrow transplant?
Most people stay in hospital for several weeks, and immunity and energy recover over months to a year.
6. What is CAR-T therapy?
A treatment in which a patient’s own T cells are modified to attack cancer cells, used for selected relapsed leukemias, lymphomas and myeloma.
7. What if a transplant is not possible?
Other treatments such as chemotherapy, targeted therapy, immunotherapy and supportive care can be used, as decided by the haematologist.
8. Can homeopathy help blood cancer patients?
Welling Homeopathy offers supportive care, including its Immuno-Knife Cancer Therapy, alongside oncology treatment, as described above; results vary from person to person.
Related Reading
- Blood Cancer: Early Signs and Symptoms to Watch Out For
- Understanding the Link Between Amyloidosis and Multiple Myeloma
- Homeopathy Specialist for Cancer
- Understanding Cancer Care at Welling Homeopathy
- 4 Step Cancer Treatment at Welling Homeopathy: Supportive Care Alongside Your Oncology Treatment
- Eating Right During Chemotherapy
To consult Welling Homeopathy experts, call +91 80 80 850 950.
Disclaimer: this page is for information only and is not a substitute for professional medical advice, diagnosis or treatment. Results vary from person to person.
